12085 Research Drive, Suite 185,
Alachua, Florida 32615
Pasteuria Bioscience, Inc. is involved in commercializing a biological solution to nematode control, a unmet agricultural pest problem. The company has producing an in-vitro form of a pathological parasite for particular species of harmful nematodes. The company is currently focused on scaling up the in-vitro production process to commercial levels.
Pasteuria Bioscience was acquired by Syngenta AG on September 19, 2012.
Join Mergr to view all 119 acquisitions of life science companies in 2012, including 19 acquisitions by private equity firms, and 100 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 19 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Pasteuria Bioscience.
No obligation. Cancel anytime.